The ability to accurately recall the shapes and spatial relationships of objects has been shown to be reduced by long-term use of anabolic-androgenic steroids (AAS), according to a recent paper.…

Jazz Pharmaceuticals plc announced that data from the largest safety trial to date of patients treated with Erwinaze® (asparaginase Erwinia chrysanthemi) based on results of a compassionate use…

A survey published in Archives of Pediatrics&Adolescent Medicine  finds that 14.2 percent of teenage children with any mental disorder have been treated with a psychotropic medication in the…

A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial. 12 patients in a trial with chronic phase CML and the…

Merck Serono, a division of Merck, has donated its 100 millionth praziquantel tablet to the World Health Organization (WHO). Schistosomiasis is the second-most prevalent tropical disease in Africa…

The European Commission has approved  Abbott's HUMIRA® (adalimumab) for the treatment of pediatric patients aged 6 to 17 years with severe active Crohn's disease (CD) who failed, are intolerant…

A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy paired with fewer side effects. To achieve this, a team of…

Some people have a distinct, disabling sleep disorder called "primary hypersomnia" - they regularly sleep more than 70 hours per week and have difficulties awakening. Even when awake, they still…

An enzyme used in nature can make powerful chemicals as diverse as catnip and a cancer drug, vinblastine, which opens up the prospect of producing these chemicals cheaply and efficiently.  "…

The All Wales Strategic Medical Group (AWSMG) has approved Zebinix(R) (eslicarbazepine acetate) for the treatment of partial seizures in highly refractory patients who remain uncontrolled with, or…